Drugs / BMS-986345
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05065866 | Nov 2021 → Jan 2024 | Hodgkins lymphoma, lymphoid leukemia, non-Hodgkin lymphoma, plasma cell myeloma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-986345 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05065866 ↗ |